Collect

4mL whole blood in EDTA (lav top).  0.5mL or >100K nucleated cells minimum

Storage/Transport Temperature

Room temperature

Remarks

Patient consent is required. To obtain consent form click here: Molecular Diagnostics Consent Form

Stability (from collection to initiation)

Ambient: several hours; Refrigerated: 5 days; Frozen: Unacceptable

Test Barcode Number

33124

Lab Section

Molecular Diagnostics

Methodology

Polymerase Chain Reaction/Melting curve analysis

Performed

1 - 2x week

Reported

5-10 working days from receipt of consent

Performing Laboratory Website (click below)

Notes

This test is not recommended for asymptomatic patients under 18 years of age.

Reference Interval

C282Y Negative: The patient is negative for the HFE C282Y mutation.

H63D Negative: The patient is negative for the HFE H63D mutation.

S65C Negative: The patient is negative for the HFE S65C mutation.

Interpretive Data

Background information for Hemochromatosis (HFE) 3 Mutations: Characteristics: Disorder of iron metabolism resulting in excessive iron storage leading to increased skin pigmentation, arthritis, hypogonadism, diabetes mellitus, heart arrhythmias/failure, cirrhosis and liver carcinoma. Incidence: One in 300 individuals of Northern European descent; unknown in other ethnicities. Inheritance: Autosomal recessive. Penetrance: 5% of C282Y homozygotes, 1% of C282Y/H63D compound heterozygotes and rare H63D homozygotes develop clinical symptoms. Cause: Two pathogenic HFE gene mutations on opposite chromosomes. Mutations Tested: p.C282Y (c.845G>A), p.H63D (c.187C>G), and p.S65C (c.193A>T).Clinical Sensitivity: 85% of hereditary hemochromatosis in Northern Europeans is caused by C282Y homozygosity and 5% by C282Y/H63D compound heterozygosity. Methodology: PCR and fluorescence monitoring. Analytical Sensitivity and Specificity: 99%. Limitations: HFE mutations, other than those targeted, will not be detected. Rare diagnostic errors may occur due to primer site mutations.
Informed consent is required by NYSDOH for genetic testing. Consent forms are available online.

CPT Codes

81256

LOINC Mapping

34519-9

Order Type (Individual or Group)

G

Group Test Information

Result Test ID Reportable Result Test Name Result Type Type (Alpha or Numeric)
C282Y Y C282Y(c.845g>aA) I A
H63D Y H63D(c.187C>G) I A
S65C Y S65C(c.193A>T)  I A
INTHF Y INTERPRETATION,HFE I N
REVHF Y REVIEWED BY: I A

Reflex Test ID

The following tests are always reflexed on . 
Result Test ID Reportable Result Test Name Result Type Type (Alpha or Numeric)
PTCST Y PATIENT CONSENT I A
PDATE Y CONSENT FORM/DISCARD DATE I A
RRHFE Y HFE REVIEW I A

CPT Codes

81256

LOINC Mapping

34519-9

Pricing

Refer to Lab Account Manager. email: labservicesoutreach@urmc.rochester.edu
Specimen Requirements

Collect

4mL whole blood in EDTA (lav top).  0.5mL or >100K nucleated cells minimum

Storage/Transport Temperature

Room temperature

Remarks

Patient consent is required. To obtain consent form click here: Molecular Diagnostics Consent Form

Stability (from collection to initiation)

Ambient: several hours; Refrigerated: 5 days; Frozen: Unacceptable

Test Barcode Number

33124

Testing

Lab Section

Molecular Diagnostics

Methodology

Polymerase Chain Reaction/Melting curve analysis

Performed

1 - 2x week

Reported

5-10 working days from receipt of consent

Performing Laboratory Website (click below)

Notes

This test is not recommended for asymptomatic patients under 18 years of age.

Result Interpretation

Reference Interval

C282Y Negative: The patient is negative for the HFE C282Y mutation.

H63D Negative: The patient is negative for the HFE H63D mutation.

S65C Negative: The patient is negative for the HFE S65C mutation.

Interpretive Data

Background information for Hemochromatosis (HFE) 3 Mutations: Characteristics: Disorder of iron metabolism resulting in excessive iron storage leading to increased skin pigmentation, arthritis, hypogonadism, diabetes mellitus, heart arrhythmias/failure, cirrhosis and liver carcinoma. Incidence: One in 300 individuals of Northern European descent; unknown in other ethnicities. Inheritance: Autosomal recessive. Penetrance: 5% of C282Y homozygotes, 1% of C282Y/H63D compound heterozygotes and rare H63D homozygotes develop clinical symptoms. Cause: Two pathogenic HFE gene mutations on opposite chromosomes. Mutations Tested: p.C282Y (c.845G>A), p.H63D (c.187C>G), and p.S65C (c.193A>T).Clinical Sensitivity: 85% of hereditary hemochromatosis in Northern Europeans is caused by C282Y homozygosity and 5% by C282Y/H63D compound heterozygosity. Methodology: PCR and fluorescence monitoring. Analytical Sensitivity and Specificity: 99%. Limitations: HFE mutations, other than those targeted, will not be detected. Rare diagnostic errors may occur due to primer site mutations.
Informed consent is required by NYSDOH for genetic testing. Consent forms are available online.

Coding

CPT Codes

81256

LOINC Mapping

34519-9
URM Labs Internal
Test Build

Order Type (Individual or Group)

G

Group Test Information

Result Test ID Reportable Result Test Name Result Type Type (Alpha or Numeric)
C282Y Y C282Y(c.845g>aA) I A
H63D Y H63D(c.187C>G) I A
S65C Y S65C(c.193A>T)  I A
INTHF Y INTERPRETATION,HFE I N
REVHF Y REVIEWED BY: I A

Reflex Test ID

The following tests are always reflexed on . 
Result Test ID Reportable Result Test Name Result Type Type (Alpha or Numeric)
PTCST Y PATIENT CONSENT I A
PDATE Y CONSENT FORM/DISCARD DATE I A
RRHFE Y HFE REVIEW I A

CPT Codes

81256

LOINC Mapping

34519-9

Pricing

Refer to Lab Account Manager. email: labservicesoutreach@urmc.rochester.edu